On July 12, 2021, Mary “Allie” Schleiff successfully defended her dissertation entitled “Diphenylamine NSAIDs are Bioactivated into Hepatotoxic Quinone-Species Metabolites”. Dr. Schleiff was mentored by Dr. Grover Paul Miller and was a trainee of the Systems Pharmacology and Toxicology (SPaT) T32 program. As a graduate student, she was an author on 15 publications, 6 of them first author. Moreover, she gave 24 oral and poster presentations, including invited talks. Based on her research efforts, she received 11 awards including Top 10 Finalist for the Sternfels Prize in Drug Safety Discoveries (2020), Third Place for the Bhuvan Award for Excellence in Biochemistry Graduate Research at UAMS (2021), and the Drug Metabolism and Disposition Highlighted Trainee Author by the American Society for Pharmacology and Experimental Therapeutics (2021). Allie has since taken a position as a postdoctoral fellow with Drs. Qin Shu and Daniel Willett at the FDA Center for Drug Evaluation and Research in St Louis, MO.
